Textextraktion: pypdf | Seiten: 5
1 Düsseldorf Local Division UPC_CFI_195/2025 UPC_CFI_568/2026 Decision of the Court of First Instance of the Unified Patent Court issued on 8 June 2026 concerning EP 4 252 857 CLAIMANTS: 1. Sanofi Biotechnologies SAS, 82 avenue Raspail, 94250 Gentily, France, represented by its chairman, Laurent Gilhodes, 2. Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591, United States of America, represented by its CEO Leonard Schleifer, all Claimants represented by: Dr. Niels Hölder, Mike Gruber, Dr. Michael Pfeifer and all other UPC Represenatives of HOFFMANN EITLE PartmbB, Daniel Wise, Agathe Michel-de Cazotte and all other UPC Rep- resentatives of CARPMEALS & RANSFORD, 1 Southampton Row WC1B 5HA London, United Kingdom, electronic address for service: nhoelder@ho ...